We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
Dr. Mary Ludlam is an established biopharma R&D leader and serial drug discovery innovator. During her decade-long tenure at Genentech, she pioneered novel technologies that delivered critical insights to multiple oncology programs, resulting in block-buster FDA-approved medicines, notably Venclexta. Mary’s broad expertise includes cell biology, high-throughput microscopy, preclinical imaging, computational analysis and biophysics. She completed her MSci and PhD in experimental physics at Imperial College of Science, Technology & Medicine, London where she received the prestigious Royal College of Science Association prize for academic and college community leadership. Mary continues to champion diversity, inclusion and technical excellence at Cairn Biosciences.
This speaker's sessions: